{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:15:53Z","timestamp":1791411353930,"version":"4.3.3"},"reference-count":202,"publisher":"Oxford University Press (OUP)","issue":"Supplement_2","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Precision medicine is part of 5 focus areas of the Challenges in IBD Research 2024 research document, which also includes preclinical human IBD mechanisms, environmental triggers, novel technologies, and pragmatic clinical research. Building on Challenges in IBD Research 2019, the current Challenges aims to provide a comprehensive overview of current gaps in inflammatory bowel diseases (IBDs) research and deliver actionable approaches to address them with a focus on how these gaps can lead to advancements in interception, remission, and restoration for these diseases. The document is the result of multidisciplinary input from scientists, clinicians, patients, and funders, and represents a valuable resource for patient-centric research prioritization. In particular, the precision medicine section is focused on the main research gaps in elucidating how to bring the best care to the individual patient in IBD. Research gaps were identified in biomarker discovery and validation for predicting disease progression and choosing the most appropriate treatment for each patient. Other gaps were identified in making the best use of existing patient biosamples and clinical data, developing new technologies to analyze large datasets, and overcoming regulatory and payer hurdles to enable clinical use of biomarkers. To address these gaps, the Workgroup suggests focusing on thoroughly validating existing candidate biomarkers, using best-in-class data generation and analysis tools, and establishing cross-disciplinary teams to tackle regulatory hurdles as early as possible. Altogether, the precision medicine group recognizes the importance of bringing basic scientific biomarker discovery and translating it into the clinic to help improve the lives of IBD patients.<\/jats:p>","DOI":"10.1093\/ibd\/izae084","type":"journal-article","created":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T13:24:37Z","timestamp":1711632277000},"page":"S39-S54","source":"Crossref","is-referenced-by-count":45,"title":["Challenges in IBD Research 2024: Precision Medicine"],"prefix":"10.1093","volume":"30","author":[{"given":"Sana","family":"Syed","sequence":"first","affiliation":[{"name":"Department of Pediatrics, University of Virginia , Charlottesville, VA ,","place":["USA"]},{"name":"Crohn\u2019s & Colitis Foundation Patient representative for , New York, NY ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigid S","family":"Boland","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California San Diego , La Jolla, CA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren T","family":"Bourke","sequence":"additional","affiliation":[{"name":"Precision Medicine Drug Development, Early Respiratory and Immunology, AstraZeneca , Boston, MA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea Ann","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, Rutgers Robert Wood Johnson Medical School , New Brunswick, NJ ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie","family":"Churchill","sequence":"additional","affiliation":[{"name":"Leona M. and Harry B. Helmsley Charitable Trust , New York, NY ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9003-5818","authenticated-orcid":false,"given":"Angela","family":"Dobes","sequence":"additional","affiliation":[{"name":"Crohn\u2019s & Colitis Foundation , New York, NY ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Greene","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Virginia , Charlottesville, VA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caren","family":"Heller","sequence":"additional","affiliation":[{"name":"Crohn\u2019s & Colitis Foundation , New York, NY ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Jayson","sequence":"additional","affiliation":[{"name":"PathAI , Boston, MA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0879-3884","authenticated-orcid":false,"given":"Benjamin","family":"Kostiuk","sequence":"additional","affiliation":[{"name":"Crohn\u2019s & Colitis Foundation , New York, NY ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Moss","sequence":"additional","affiliation":[{"name":"Crohn\u2019s & Colitis Foundation , New York, NY ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fedaa","family":"Najdawi","sequence":"additional","affiliation":[{"name":"PathAI , Boston, MA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Plung","sequence":"additional","affiliation":[{"name":"Crohn\u2019s & Colitis Foundation Patient representative for , New York, NY ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D","family":"Rioux","sequence":"additional","affiliation":[{"name":"Research Center, Montreal Heart Institute, Universit\u00e9 de Montr\u00e9al , Montr\u00e9al, Qu\u00e9bec ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J","family":"Rosen","sequence":"additional","affiliation":[{"name":"Division of Pediatric Gastroenterology, Department of Pediatrics, Stanford University School of Medicine , Stanford, CA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2895-5821","authenticated-orcid":false,"given":"Joana","family":"Torres","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hospital Beatriz \u00c2ngelo, Hospital da Luz, Lisbon ,","place":["Portugal"]},{"name":"Faculdade de Medicina, Universidade de Lisboa , Lisbon ,","place":["Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Zulqarnain","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Virginia , Charlottesville, VA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Satsangi","sequence":"additional","affiliation":[{"name":"Translational Gastroenterology Unit, Experimental Medicine Division, Nuffield Department of Medicine, John Radcliffe Hospital, University of Oxford , Oxford ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,5,23]]},"reference":[{"key":"2026071707065383300_CIT0001","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3389\/fmed.2018.00075","article-title":"Inflammatory bowel disease: complexity and variability need integration","volume":"5","author":"Fiocchi","year":"2018","journal-title":"Front Med (Lausanne)"},{"issue":"12","key":"2026071707065383300_CIT0002","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1080\/14737159.2023.2279611","article-title":"Current and emerging biomarkers for ulcerative colitis","volume":"23","author":"Nowak","year":"2023","journal-title":"Expert Rev Mol Diagn."},{"issue":"5","key":"2026071707065383300_CIT0003","doi-asserted-by":"crossref","first-page":"e00486","DOI":"10.14309\/ctg.0000000000000486","article-title":"AGPAT1 as a novel colonic biomarker for discriminating between ulcerative colitis with and without primary sclerosing cholangitis","volume":"13","author":"Vessby","year":"2022","journal-title":"Clin Transl Gastroenterol"},{"issue":"2","key":"2026071707065383300_CIT0004","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/ecco-jcc\/jjac127","article-title":"Analysis of systemic epigenetic alterations in inflammatory bowel disease: defining geographical, genetic and immune-inflammatory influences on the circulating methylome","volume":"17","author":"Kalla","year":"2023","journal-title":"J Crohns Colitis."},{"issue":"4","key":"2026071707065383300_CIT0005","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1053\/j.gastro.2022.12.042","article-title":"Anti-integrin \u03b1v\u03b26 autoantibodies are a novel biomarker that antedate ulcerative colitis","volume":"164","author":"Livanos","year":"2023","journal-title":"Gastroenterology."},{"issue":"4","key":"2026071707065383300_CIT0006","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/MPG.0000000000003359","article-title":"Anti-proteinase 3 antibodies as a biomarker for ulcerative colitis and primary sclerosing cholangitis in children","volume":"74","author":"Laass","year":"2022","journal-title":"J Pediatr Gastroenterol Nutr."},{"issue":"7","key":"2026071707065383300_CIT0007","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1136\/gutjnl-2021-326451","article-title":"Biopsy and blood-based molecular biomarker of inflammation in IBD","volume":"72","author":"Argmann","year":"2023","journal-title":"Gut."},{"issue":"8","key":"2026071707065383300_CIT0008","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1053\/j.gastro.2019.01.270","article-title":"Blood-derived DNA methylation signatures of Crohn\u2019s disease and severity of intestinal inflammation","volume":"156","author":"Somineni","year":"2019","journal-title":"Gastroenterology."},{"issue":"1","key":"2026071707065383300_CIT0009","doi-asserted-by":"crossref","first-page":"e00452","DOI":"10.14309\/ctg.0000000000000452","article-title":"Circulating dipeptidyl peptidase activity is a potential biomarker for inflammatory bowel disease","volume":"13","author":"Jaenisch","year":"2022","journal-title":"Clin Transl Gastroenterol"},{"issue":"19","key":"2026071707065383300_CIT0010","doi-asserted-by":"crossref","first-page":"5618","DOI":"10.3390\/jcm11195618","article-title":"Circulating profile of ECM-related proteins as diagnostic markers in inflammatory bowel diseases","volume":"11","author":"Komosinska-Vassev","year":"2022","journal-title":"J Clin Med"},{"issue":"5","key":"2026071707065383300_CIT0011","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1053\/j.gastro.2020.12.034","article-title":"Common and rare variant prediction and penetrance of IBD in a large, multi-ethnic, health system-based biobank cohort","volume":"160","author":"Gettler","year":"2021","journal-title":"Gastroenterology."},{"issue":"2","key":"2026071707065383300_CIT0012","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s10620-018-5357-0","article-title":"Detectable laboratory abnormality is present up to 12 months prior to diagnosis in patients with Crohn\u2019s disease","volume":"64","author":"Irwin","year":"2019","journal-title":"Dig Dis Sci."},{"issue":"8","key":"2026071707065383300_CIT0013","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1053\/j.gastro.2020.02.012","article-title":"Development and validation of a deep neural network for accurate evaluation of endoscopic images from patients with ulcerative colitis","volume":"158","author":"Takenaka","year":"2020","journal-title":"Gastroenterology."},{"issue":"3","key":"2026071707065383300_CIT0014","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1053\/j.gastro.2023.05.032","article-title":"Gut microbiome composition is associated with future onset of Crohn\u2019s disease in healthy first-degree relatives","volume":"165","author":"Raygoza Garay","year":"2023","journal-title":"Gastroenterology."},{"issue":"4","key":"2026071707065383300_CIT0015","doi-asserted-by":"crossref","first-page":"e00469","DOI":"10.14309\/ctg.0000000000000469","article-title":"Identification of immunoglobulin g autoantibody against malondialdehyde-acetaldehyde adducts as a novel serological biomarker for ulcerative colitis","volume":"13","author":"Duryee","year":"2022","journal-title":"Clin Transl Gastroenterol"},{"issue":"8","key":"2026071707065383300_CIT0016","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1136\/gutjnl-2022-328421","article-title":"Immune response and barrier dysfunction-related proteomic signatures in preclinical phase of Crohn\u2019s disease highlight earliest events of pathogenesis","volume":"72","author":"Leibovitzh","year":"2023","journal-title":"Gut."},{"issue":"9","key":"2026071707065383300_CIT0017","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/s41588-022-01156-2","article-title":"Large-scale sequencing identifies multiple genes and rare variants associated with Crohn\u2019s disease susceptibility","volume":"54","author":"Sazonovs","year":"2022","journal-title":"Nat Genet."},{"key":"2026071707065383300_CIT0018","doi-asserted-by":"crossref","first-page":"872671","DOI":"10.3389\/fmicb.2022.872671","article-title":"Machine learning based microbiome signature to predict inflammatory bowel disease subtypes","volume":"13","author":"Li\u00f1ares-Blanco","year":"2022","journal-title":"Front Microbiol."},{"issue":"2","key":"2026071707065383300_CIT0019","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/apt.16136","article-title":"Machine learning identifies novel blood protein predictors of penetrating and stricturing complications in newly diagnosed paediatric Crohn\u2019s disease","volume":"53","author":"Ungaro","year":"2021","journal-title":"Aliment Pharmacol Ther."},{"issue":"20","key":"2026071707065383300_CIT0020","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.3390\/jcm10204745","article-title":"Machine learning prediction model for inflammatory bowel disease based on laboratory markers. Working Model in a Discovery Cohort Study","volume":"10","author":"Kraszewski","year":"2021","journal-title":"J Clin Med"},{"issue":"7","key":"2026071707065383300_CIT0021","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.3390\/jcm11071881","article-title":"Measurement of serum IgG anti-integrin \u03b1v\u03b26 autoantibodies is a promising tool in the diagnosis of ulcerative colitis","volume":"11","author":"Rydell","year":"2022","journal-title":"J Clin Med"},{"issue":"1","key":"2026071707065383300_CIT0022","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10620-022-07547-z","article-title":"Neutrophil-to-lymphocyte ratio: an easy marker for the diagnosis and monitoring of inflammatory bowel disease in children","volume":"68","author":"\u015eim\u015fek-Onat","year":"2023","journal-title":"Dig Dis Sci."},{"issue":"5","key":"2026071707065383300_CIT0023","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1053\/j.gastro.2020.12.004","article-title":"Novel fecal biomarkers that precede clinical diagnosis of ulcerative colitis","volume":"160","author":"Galipeau","year":"2021","journal-title":"Gastroenterology."},{"issue":"6","key":"2026071707065383300_CIT0024","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/MPG.0000000000003846","article-title":"NOD2 polymorphisms may direct a Crohn disease phenotype in patients with very early-onset inflammatory bowel disease","volume":"77","author":"Watson","year":"2023","journal-title":"J Pediatr Gastroenterol Nutr."},{"issue":"1","key":"2026071707065383300_CIT0025","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.gastro.2020.03.007","article-title":"Serum biomarkers identify patients who will develop inflammatory bowel diseases up to 5 years before diagnosis","volume":"159","author":"Torres","year":"2020","journal-title":"Gastroenterology."},{"issue":"5","key":"2026071707065383300_CIT0026","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/ecco-jcc\/jjaa230","article-title":"Serum proteomic profiling at diagnosis predicts clinical course, and need for intensification of treatment in inflammatory bowel disease","volume":"15","author":"Kalla","year":"2021","journal-title":"J Crohns Colitis."},{"issue":"5","key":"2026071707065383300_CIT0027","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1053\/j.gastro.2021.07.026","article-title":"Systemic inflammation in preclinical ulcerative colitis","volume":"161","author":"Bergemalm","year":"2021","journal-title":"Gastroenterology."},{"key":"2026071707065383300_CIT0028","doi-asserted-by":"crossref","first-page":"1122005","DOI":"10.3389\/fmed.2023.1122005","article-title":"The value of 7 peripheral blood serum ratios in diagnosis and prediction of disease activity of patients within inflammatory bowel disease individuals","volume":"10","author":"Pan","year":"2023","journal-title":"Fron Med"},{"issue":"12","key":"2026071707065383300_CIT0029","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/ecco-jcc\/jjaa134","article-title":"Whole blood profiling of T-cell-derived microRNA allows the development of prognostic models in inflammatory bowel disease","volume":"14","author":"Kalla","year":"2020","journal-title":"J Crohns Colitis."},{"issue":"10","key":"2026071707065383300_CIT0030","doi-asserted-by":"crossref","first-page":"4874","DOI":"10.1007\/s10620-022-07506-8","article-title":"Artificial intelligence for Inflammatory Bowel Diseases (IBD); accurately predicting adverse outcomes using machine learning","volume":"67","author":"Zand","year":"2022","journal-title":"Dig Dis Sci."},{"issue":"9","key":"2026071707065383300_CIT0031","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1093\/ecco-jcc\/jjac047","article-title":"A specific calprotectin neo-epitope [CPa9-HNE] in serum from inflammatory bowel disease patients is associated with neutrophil activity and endoscopic severity","volume":"16","author":"Mortensen","year":"2022","journal-title":"J Crohns Colitis."},{"issue":"6","key":"2026071707065383300_CIT0032","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.ajpath.2022.03.006","article-title":"Deep learning analysis of histologic images from intestinal specimen reveals adipocyte shrinkage and mast cell infiltration to predict postoperative Crohn disease","volume":"192","author":"Kiyokawa","year":"2022","journal-title":"Am J Pathol."},{"issue":"12","key":"2026071707065383300_CIT0033","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1007\/s00535-022-01924-1","article-title":"Deep learning-based automated quantification of goblet cell mucus using histological images as a predictor of clinical relapse of ulcerative colitis with endoscopic remission","volume":"57","author":"Ohara","year":"2022","journal-title":"J Gastroenterol."},{"issue":"6","key":"2026071707065383300_CIT0034","first-page":"609","article-title":"Elevated serum globulin fraction as a biomarker of multiyear disease severity in inflammatory bowel disease","volume":"35","author":"Hashash","year":"2022","journal-title":"Ann Gastroenterol"},{"issue":"5","key":"2026071707065383300_CIT0035","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/ibd\/izab134","article-title":"Endoscopic prediction of Crohn\u2019s disease postoperative recurrence","volume":"28","author":"De Cruz","year":"2022","journal-title":"Inflamm Bowel Dis."},{"issue":"4","key":"2026071707065383300_CIT0036","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.gie.2021.10.019","article-title":"Evaluation in real-time use of artificial intelligence during colonoscopy to predict relapse of ulcerative colitis: a prospective study","volume":"95","author":"Maeda","year":"2022","journal-title":"Gastrointest Endosc."},{"issue":"4","key":"2026071707065383300_CIT0037","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1053\/j.gastro.2022.06.045","article-title":"Exhaustion of CD39-expressing CD8+ T cells in Crohn\u2019s disease is linked to clinical outcome","volume":"163","author":"Globig","year":"2022","journal-title":"Gastroenterology."},{"issue":"12","key":"2026071707065383300_CIT0038","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1093\/ecco-jcc\/jjac098","article-title":"Faecal myeloperoxidase as a biomarker of endoscopic activity in inflammatory bowel disease","volume":"16","author":"Swaminathan","year":"2022","journal-title":"J Crohns Colitis."},{"issue":"2","key":"2026071707065383300_CIT0039","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/s41385-019-0235-4","article-title":"Faecal neutrophil elastase-antiprotease balance reflects colitis severity","volume":"13","author":"Barry","year":"2020","journal-title":"Mucosal Immunol"},{"issue":"4","key":"2026071707065383300_CIT0040","doi-asserted-by":"crossref","first-page":"e0231796","DOI":"10.1371\/journal.pone.0231796","article-title":"High circulating elafin levels are associated with Crohn\u2019s disease-associated intestinal strictures","volume":"15","author":"Wang","year":"2020","journal-title":"PLoS One."},{"issue":"19","key":"2026071707065383300_CIT0041","doi-asserted-by":"crossref","first-page":"5907","DOI":"10.3390\/jcm11195907","article-title":"Inflammatory biomarkers of extracellular matrix remodeling and disease activity in Crohn\u2019s disease and ulcerative colitis","volume":"11","author":"Domislovic","year":"2022","journal-title":"J Clin Med"},{"issue":"4","key":"2026071707065383300_CIT0042","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1620\/tjem.2022.J042","article-title":"Leucine-rich alpha-2 glycoprotein in monitoring disease activity and intestinal stenosis in inflammatory bowel disease","volume":"257","author":"Yoshida","year":"2022","journal-title":"Tohoku J Exp Med."},{"issue":"9","key":"2026071707065383300_CIT0043","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1093\/ibd\/izac230","article-title":"Leucine-rich alpha-2 glycoprotein is a reliable serum biomarker for evaluating clinical and endoscopic disease activity in inflammatory bowel disease","volume":"29","author":"Shimoyama","year":"2023","journal-title":"Inflamm Bowel Dis."},{"issue":"5","key":"2026071707065383300_CIT0044","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/ibd\/izab311","article-title":"Meta-analysis of IBD gut samples gene expression identifies specific markers of ileal and colonic diseases","volume":"28","author":"Perez","year":"2022","journal-title":"Inflamm Bowel Dis."},{"issue":"6","key":"2026071707065383300_CIT0045","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1053\/j.gastro.2021.08.053","article-title":"Molecular characterization of limited ulcerative colitis reveals novel biology and predictors of disease extension","volume":"161","author":"Argmann","year":"2021","journal-title":"Gastroenterology."},{"issue":"1","key":"2026071707065383300_CIT0046","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/ibd\/izab031","article-title":"Monocytosis is a biomarker of severity in inflammatory bowel disease: analysis of a 6-year prospective Natural History Registry","volume":"28","author":"Anderson","year":"2022","journal-title":"Inflamm Bowel Dis."},{"issue":"4","key":"2026071707065383300_CIT0047","first-page":"504","article-title":"New non-invasive biomarkers of intestinal inflammation and increased intestinal permeability in pediatric inflammatory bowel diseases and their correlation with fecal calprotectin: a pilot study","volume":"69","author":"Szymanska","year":"2022","journal-title":"Minerva Gastroenterol"},{"issue":"10","key":"2026071707065383300_CIT0048","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1093\/ibd\/izab032","article-title":"Oncostatin M is a biomarker of diagnosis, worse disease prognosis, and therapeutic nonresponse in inflammatory bowel disease","volume":"27","author":"Verstockt","year":"2021","journal-title":"Inflamm Bowel Dis."},{"issue":"6","key":"2026071707065383300_CIT0049","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.14309\/ajg.0000000000002127","article-title":"Serum leucine-rich \u03b12 glycoprotein: a novel biomarker for transmural inflammation in Crohn\u2019s disease","volume":"118","author":"Takenaka","year":"2023","journal-title":"Am J Gastroenterol."},{"key":"2026071707065383300_CIT0050","first-page":"9171436","article-title":"The correlation between endotoxin, D-lactate, and diamine oxidase with endoscopic activity in inflammatory bowel disease","volume":"2022","author":"Zhang","year":"2022","journal-title":"Dis Markers."},{"issue":"1","key":"2026071707065383300_CIT0051","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/ibd\/izab123","article-title":"Serum analyte profiles associated with Crohn\u2019s disease and disease location","volume":"28","author":"Boucher","year":"2022","journal-title":"Inflamm Bowel Dis."},{"issue":"7","key":"2026071707065383300_CIT0052","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1093\/ibd\/izac281","article-title":"Serum lipidomic screen identifies key metabolites, pathways, and disease classifiers in Crohn\u2019s disease","volume":"29","author":"Ferru-Cl\u00e9ment","year":"2023","journal-title":"Inflamm Bowel Dis."},{"issue":"11","key":"2026071707065383300_CIT0053","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1093\/ibd\/izz061","article-title":"Association of infliximab levels with mucosal healing is time-dependent in Crohn\u2019s disease: higher drug exposure is required postinduction than during maintenance treatment","volume":"25","author":"Feng","year":"2019","journal-title":"Inflamm Bowel Dis."},{"issue":"12","key":"2026071707065383300_CIT0054","doi-asserted-by":"crossref","first-page":"e0277576","DOI":"10.1371\/journal.pone.0277576","article-title":"Association between ustekinumab therapy and changes in specific anti-microbial response, serum biomarkers, and microbiota composition in patients with IBD: a pilot study","volume":"17","author":"Rob","year":"2022","journal-title":"PLoS One."},{"issue":"1","key":"2026071707065383300_CIT0055","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/ecco-jcc\/jjy139","article-title":"A [glyco]biomarker that predicts failure to standard therapy in ulcerative colitis patients","volume":"13","author":"Pereira","year":"2019","journal-title":"J Crohns Colitis."},{"issue":"4","key":"2026071707065383300_CIT0056","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.3390\/ijms24043955","article-title":"90K\/Mac-2 BP is a new predictive biomarker of response to infliximab therapy in IBD patients","volume":"24","author":"Pesole","year":"2023","journal-title":"Int J Mol Sci ."},{"issue":"4","key":"2026071707065383300_CIT0057","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1136\/gutjnl-2017-315494","article-title":"Cell-centred meta-analysis reveals baseline predictors of anti-TNF\u03b1 non-response in biopsy and blood of patients with IBD","volume":"68","author":"Gaujoux","year":"2019","journal-title":"Gut."},{"issue":"3","key":"2026071707065383300_CIT0058","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s10620-018-5362-3","article-title":"Correlation between anti-TNF serum levels and endoscopic inflammation in inflammatory bowel disease patients","volume":"64","author":"Chaparro","year":"2019","journal-title":"Dig Dis Sci."},{"issue":"9","key":"2026071707065383300_CIT0059","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/ibd\/izab285","article-title":"Dashboard-driven accelerated infliximab induction dosing increases infliximab durability and reduces immunogenicity","volume":"28","author":"Dubinsky","year":"2022","journal-title":"Inflamm Bowel Dis."},{"issue":"2","key":"2026071707065383300_CIT0060","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jcmgh.2021.03.012","article-title":"Deep analysis of the peripheral immune system in IBD reveals new insight in disease subtyping and response to monotherapy or combination therapy","volume":"12","author":"Kosoy","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"6","key":"2026071707065383300_CIT0061","first-page":"947","article-title":"Development of a machine learning model to predict non-durable response to anti-TNF therapy in Crohn\u2019s disease using transcriptome imputed from genotypes","volume":"12","author":"Park","year":"2022","journal-title":"J Med."},{"issue":"6","key":"2026071707065383300_CIT0062","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.3390\/ijms24065820","article-title":"Differences in whole-blood transcriptional profiles in inflammatory bowel disease patients responding to vedolizumab compared with non-responders","volume":"24","author":"Haglund","year":"2023","journal-title":"Int J Mol Sci ."},{"issue":"8","key":"2026071707065383300_CIT0063","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1136\/gutjnl-2020-322100","article-title":"Discovery of biomarker candidates associated with the risk of short-term and mid\/long-term relapse after infliximab withdrawal in Crohn\u2019s patients: a proteomics-based study","volume":"70","author":"Pierre","year":"2021","journal-title":"Gut."},{"issue":"11","key":"2026071707065383300_CIT0064","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1111\/apt.16333","article-title":"Early detection of anti-drug antibodies during initiation of anti-tumour necrosis factor therapy predicts treatment discontinuation in inflammatory bowel disease","volume":"53","author":"Tournier","year":"2021","journal-title":"Aliment Pharmacol Ther."},{"issue":"2","key":"2026071707065383300_CIT0065","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/00365521.2020.1856405","article-title":"Efficacy of dashboard driven dosing of infliximab in inflammatory bowel disease patients; a randomized controlled trial","volume":"56","author":"Strik","year":"2021","journal-title":"Scand J Gastroenterol."},{"issue":"3","key":"2026071707065383300_CIT0066","first-page":"otz026","article-title":"Elevated pretreatment plasma oncostatin M is associated with poor biochemical response to infliximab","volume":"1","author":"Minar","year":"2019","journal-title":"Crohns Colitis 360."},{"issue":"5","key":"2026071707065383300_CIT0067","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1136\/gutjnl-2017-315671","article-title":"Expansion of IL-23 receptor bearing TNFR2+ T cells is associated with molecular resistance to anti-TNF therapy in Crohn\u2019s disease","volume":"68","author":"Schmitt","year":"2019","journal-title":"Gut."},{"issue":"5","key":"2026071707065383300_CIT0068","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.cgh.2019.08.030","article-title":"Expression levels of 4 genes in colon tissue might be used to predict which patients will enter endoscopic remission after vedolizumab therapy for inflammatory bowel diseases","volume":"18","author":"Verstockt","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"2026071707065383300_CIT0069","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1053\/j.gastro.2020.03.073","article-title":"Extended analysis identifies drug-specific association of 2 distinct HLA class II haplotypes for development of immunogenicity to adalimumab and infliximab","volume":"159","author":"Powell Doherty","year":"2020","journal-title":"Gastroenterology."},{"issue":"10","key":"2026071707065383300_CIT0070","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1080\/00365521.2020.1803396","article-title":"Faecal microbiota signatures of IBD and their relation to diagnosis, disease phenotype, inflammation, treatment escalation and anti-TNF response in a European Multicentre Study (IBD-Character)","volume":"55","author":"Vatn","year":"2020","journal-title":"Scand J Gastroenterol."},{"issue":"3","key":"2026071707065383300_CIT0071","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/s41591-023-02217-7","article-title":"Gut microbial metabolism of 5-ASA diminishes its clinical efficacy in inflammatory bowel disease","volume":"29","author":"Mehta","year":"2023","journal-title":"Nat Med."},{"issue":"7","key":"2026071707065383300_CIT0072","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1007\/s10620-021-07088-x","article-title":"High anti-infliximab antibody titers do not impact response to subsequent adalimumab treatment in inflammatory bowel diseases","volume":"67","author":"Sasson","year":"2022","journal-title":"Dig Dis Sci."},{"issue":"1","key":"2026071707065383300_CIT0073","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/s41598-022-05208-9","article-title":"High oncostatin M predicts lack of clinical remission for patients with inflammatory bowel disease on tumor necrosis factor \u03b1 antagonists","volume":"12","author":"Guo","year":"2022","journal-title":"Sci Rep."},{"issue":"1","key":"2026071707065383300_CIT0074","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/ibd\/izy217","article-title":"Higher postinduction infliximab serum trough levels are associated with healing of fistulizing perianal Crohn\u2019s disease in children","volume":"25","author":"El-Matary","year":"2019","journal-title":"Inflamm Bowel Dis."},{"issue":"1","key":"2026071707065383300_CIT0075","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1053\/j.gastro.2019.09.041","article-title":"HLA-DQA1*05 carriage associated with development of anti-drug antibodies to infliximab and adalimumab in patients with Crohn\u2019s disease","volume":"158","author":"Sazonovs","year":"2020","journal-title":"Gastroenterology."},{"issue":"11","key":"2026071707065383300_CIT0076","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1038\/s41591-021-01520-5","article-title":"IL-1-driven stromal\u2013neutrophil interactions define a subset of patients with inflammatory bowel disease that does not respond to therapies","volume":"27","author":"Friedrich","year":"2021","journal-title":"Nat Med."},{"issue":"5","key":"2026071707065383300_CIT0077","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1172\/JCI121668","article-title":"IL-7 receptor influences anti-TNF responsiveness and T cell gut homing in inflammatory bowel disease","volume":"129","author":"Belarif","year":"2019","journal-title":"J Clin Invest."},{"key":"2026071707065383300_CIT0078","doi-asserted-by":"crossref","first-page":"996875","DOI":"10.3389\/fimmu.2022.996875","article-title":"Increased monocyte abundance as a marker for relapse after discontinuation of biologics in inflammatory bowel disease with deep remission","volume":"13","author":"Kwon","year":"2022","journal-title":"Front Immunol."},{"issue":"2","key":"2026071707065383300_CIT0079","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/ecco-jcc\/jjy155","article-title":"Infliximab trough levels are associated with mucosal healing during maintenance treatment with infliximab in paediatric Crohn\u2019s disease","volume":"13","author":"Kang","year":"2019","journal-title":"J Crohns Colitis."},{"key":"2026071707065383300_CIT0080","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.1065297","article-title":"Landscape of sialylation patterns identify biomarkers for diagnosis and prediction of response to anti-TNF therapy in Crohn\u2019s disease","volume":"13","author":"Ye","year":"2022","journal-title":"Front Genet."},{"issue":"5","key":"2026071707065383300_CIT0081","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/apt.16478","article-title":"Limited long-term treatment persistence of first anti-TNF therapy in 538 patients with inflammatory bowel diseases: a 20-year real-world study","volume":"54","author":"Blesl","year":"2021","journal-title":"Aliment Pharmacol Ther."},{"issue":"2","key":"2026071707065383300_CIT0082","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/apt.16955","article-title":"Longitudinal monitoring of STAT3 phosphorylation and histologic outcome of tofacitinib therapy in patients with ulcerative colitis","volume":"56","author":"Verstockt","year":"2022","journal-title":"Aliment Pharmacol Ther."},{"issue":"1","key":"2026071707065383300_CIT0083","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13073-022-01112-z","article-title":"Longitudinal multi-omics analysis identifies early blood-based predictors of anti-TNF therapy response in inflammatory bowel disease","volume":"14","author":"Mishra","year":"2022","journal-title":"Genome Med."},{"key":"2026071707065383300_CIT0084","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ebiom.2019.01.027","article-title":"Low TREM1 expression in whole blood predicts anti-TNF response in inflammatory bowel disease","volume":"40","author":"Verstockt","year":"2019","journal-title":"EBioMedicine"},{"issue":"5","key":"2026071707065383300_CIT0085","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1053\/j.gastro.2019.07.025","article-title":"Metabolic functions of gut microbes associate with efficacy of tumor necrosis factor antagonists in patients with inflammatory bowel diseases","volume":"157","author":"Aden","year":"2019","journal-title":"Gastroenterology."},{"key":"2026071707065383300_CIT0086","doi-asserted-by":"crossref","first-page":"627535","DOI":"10.3389\/fimmu.2021.627535","article-title":"Monocyte TREM-1 levels associate with anti-TNF responsiveness in IBD through autophagy and Fc\u03b3-receptor signaling pathways","volume":"12","author":"Prins","year":"2021","journal-title":"Front Immunol."},{"issue":"14","key":"2026071707065383300_CIT0087","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.3390\/jcm11144141","article-title":"Mucosal eosinophil abundance in non-inflamed colonic tissue is associated with response to vedolizumab induction therapy in inflammatory bowel disease","volume":"11","author":"Gabri\u00ebls","year":"2022","journal-title":"J Clin Med"},{"issue":"5","key":"2026071707065383300_CIT0088","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/apt.15126","article-title":"Mucosal IL13RA2 expression predicts nonresponse to anti-TNF therapy in Crohn\u2019s disease","volume":"49","author":"Verstockt","year":"2019","journal-title":"Aliment Pharmacol Ther."},{"issue":"10","key":"2026071707065383300_CIT0089","doi-asserted-by":"crossref","first-page":"e00401","DOI":"10.14309\/ctg.0000000000000401","article-title":"Post-induction high adalimumab drug levels predict biological remission at week 24 in patients with Crohn\u2019s disease","volume":"12","author":"Zittan","year":"2021","journal-title":"Clin Transl Gastroenterol"},{"issue":"4","key":"2026071707065383300_CIT0090","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1177\/2050640620912877","article-title":"Post-induction infliximab trough levels and disease activity in the clinical evolution of pediatric ulcerative colitis","volume":"8","author":"Moore","year":"2020","journal-title":"United Eur Gastroenterol J"},{"issue":"2","key":"2026071707065383300_CIT0091","doi-asserted-by":"crossref","first-page":"e24130","DOI":"10.1002\/jcla.24130","article-title":"Potential role of MALT1 as a candidate biomarker of disease surveillance and treatment response prediction in inflammatory bowel disease patients","volume":"36","author":"Wu","year":"2022","journal-title":"J Clin Lab Anal."},{"issue":"5","key":"2026071707065383300_CIT0092","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S2468-1253(19)30012-3","article-title":"Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn\u2019s disease: a prospective, multicentre, cohort study","volume":"4","author":"Kennedy","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"2026071707065383300_CIT0093","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1053\/j.gastro.2019.06.003","article-title":"Proactive monitoring of adalimumab trough concentration associated with increased clinical remission in children with Crohn\u2019s disease compared with reactive monitoring","volume":"157","author":"Assa","year":"2019","journal-title":"Gastroenterology."},{"issue":"9","key":"2026071707065383300_CIT0094","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.3390\/biomedicines10092305","article-title":"Prognostic role of post-induction fecal calprotectin levels in patients with inflammatory bowel disease treated with biological therapies","volume":"10","author":"Facciorusso","year":"2022","journal-title":"Biomedicines"},{"issue":"3","key":"2026071707065383300_CIT0095","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3390\/pharmaceutics15030817","article-title":"Radioimmune imaging of \u03b14\u03b27 integrin and TNF\u03b1 for diagnostic and therapeutic applications in inflammatory bowel disease","volume":"15","author":"Signore","year":"2023","journal-title":"Pharmaceutics"},{"issue":"6","key":"2026071707065383300_CIT0096","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/cpt.2148","article-title":"Real-world infliximab pharmacokinetic study informs an electronic health record-embedded dashboard to guide precision dosing in children with Crohn\u2019s disease","volume":"109","author":"Xiong","year":"2021","journal-title":"Clin Pharmacol Ther."},{"issue":"6","key":"2026071707065383300_CIT0097","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/ecco-jcc\/jjad012","article-title":"Serum N-glycomic biomarkers predict treatment escalation in inflammatory bowel disease","volume":"17","author":"Shubhakar","year":"2023","journal-title":"J Crohns Colitis."},{"issue":"2","key":"2026071707065383300_CIT0098","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/apt.15870","article-title":"Serum oncostatin M at baseline predicts mucosal healing in Crohn\u2019s disease patients treated with infliximab","volume":"52","author":"Bertani","year":"2020","journal-title":"Aliment Pharmacol Ther."},{"issue":"12","key":"2026071707065383300_CIT0099","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1093\/ibd\/izac151","article-title":"Transcriptional behavior of regulatory T cells predicts IBD patient responses to vedolizumab therapy","volume":"28","author":"Abreu","year":"2022","journal-title":"Inflamm Bowel Dis."},{"issue":"1","key":"2026071707065383300_CIT0100","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41467-018-07841-3","article-title":"Ulcerative colitis mucosal transcriptomes reveal mitochondriopathy and personalized mechanisms underlying disease severity and treatment response","volume":"10","author":"Haberman","year":"2019","journal-title":"Nat Commun."},{"issue":"5","key":"2026071707065383300_CIT0101","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/apt.17089","article-title":"Understanding anti-TNF treatment failure: does serum triiodothyronine-to-thyroxine (T3\/T4) ratio predict therapeutic outcome to anti-TNF therapies in biologic-na\u00efve patients with active luminal Crohn\u2019s disease","volume":"56","author":"Lin","year":"2022","journal-title":"Aliment Pharmacol Ther."},{"issue":"10","key":"2026071707065383300_CIT0102","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/ecco-jcc\/jjz057","article-title":"Early initiation of anti-TNF is associated with favourable long-term outcome in Crohn\u2019s disease: 10-year-follow-up data from the Swiss IBD cohort study","volume":"13","author":"Frei","year":"2019","journal-title":"J Crohns Colitis."},{"issue":"8","key":"2026071707065383300_CIT0103","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1093\/ecco-jcc\/jjaa039","article-title":"Metabonomics and the gut microbiome associated with primary response to anti-TNF therapy in Crohn\u2019s disease","volume":"14","author":"Ding","year":"2020","journal-title":"J Crohns Colitis."},{"issue":"8","key":"2026071707065383300_CIT0104","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.chom.2021.06.019","article-title":"Multi-omics reveal microbial determinants impacting responses to biologic therapies in inflammatory bowel disease","volume":"29","author":"Lee","year":"2021","journal-title":"Cell Host Microbe."},{"issue":"6","key":"2026071707065383300_CIT0105","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.cell.2019.08.008","article-title":"Single-cell analysis of Crohn\u2019s disease lesions identifies a pathogenic cellular module associated with resistance to anti-TNF therapy","volume":"178","author":"Martin","year":"2019","journal-title":"Cell."},{"issue":"7","key":"2026071707065383300_CIT0106","doi-asserted-by":"crossref","first-page":"6054","DOI":"10.3390\/ijms24076054","article-title":"Single-cell sequencing-based validation of T cell-associated diagnostic model genes and drug response in Crohn\u2019s disease","volume":"24","author":"Dai","year":"2023","journal-title":"Int J Mol Sci ."},{"key":"2026071707065383300_CIT0107","author":"Abraham"},{"issue":"3","key":"2026071707065383300_CIT0108","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/ecco-jcc\/jjy162","article-title":"GlycA, a nuclear magnetic resonance spectroscopy measure for protein glycosylation, is a viable biomarker for disease activity in IBD","volume":"13","author":"Dierckx","year":"2019","journal-title":"J Crohns Colitis."},{"issue":"2","key":"2026071707065383300_CIT0109","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.crad.2021.10.006","article-title":"Automatic detection of Crohn\u2019s disease using quantified motility in magnetic resonance enterography: initial experiences","volume":"77","author":"Arkko","year":"2022","journal-title":"Clin Radiol."},{"issue":"10","key":"2026071707065383300_CIT0110","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1136\/gutjnl-2019-320056","article-title":"Automatic, computer-aided determination of endoscopic and histological inflammation in patients with mild to moderate ulcerative colitis based on red density","volume":"69","author":"Bossuyt","year":"2020","journal-title":"Gut."},{"issue":"8","key":"2026071707065383300_CIT0111","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1111\/jgh.15933","article-title":"Implementing precision medicine in endoscopy practice","volume":"37","author":"Kuo","year":"2022","journal-title":"J Gastroenterol Hepatol."},{"issue":"7","key":"2026071707065383300_CIT0112","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.cell.2020.05.001","article-title":"Personalized mapping of drug metabolism by the human gut microbiome","volume":"181","author":"Javdan","year":"2020","journal-title":"Cell."},{"issue":"5","key":"2026071707065383300_CIT0113","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1136\/gutjnl-2021-326376","article-title":"PICaSSO Histologic Remission Index (PHRI) in ulcerative colitis: development of a novel simplified histological score for monitoring mucosal healing and predicting clinical outcomes and its applicability in an artificial intelligence system","volume":"71","author":"Gui","year":"2022","journal-title":"Gut."},{"issue":"1","key":"2026071707065383300_CIT0114","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/ecco-jcc\/jjac110","article-title":"Proteomic analysis identifies three reliable biomarkers of intestinal inflammation in the stools of patients with inflammatory bowel disease","volume":"17","author":"Vitali","year":"2023","journal-title":"J Crohns Colitis."},{"issue":"6","key":"2026071707065383300_CIT0115","doi-asserted-by":"crossref","first-page":"e13960","DOI":"10.1111\/eci.13960","article-title":"Artificial-intelligence-based decision support tools for the differential diagnosis of colitis","volume":"53","author":"Guimar\u00e3es","year":"2023","journal-title":"Eur J Clin Invest."},{"issue":"3","key":"2026071707065383300_CIT0116","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s11517-021-02486-9","article-title":"Automated detection of ulcers and erosions in capsule endoscopy images using a convolutional neural network","volume":"60","author":"Afonso","year":"2022","journal-title":"Med Biol Eng Comput."},{"issue":"2","key":"2026071707065383300_CIT0117","doi-asserted-by":"crossref","first-page":"e0263248","DOI":"10.1371\/journal.pone.0263248","article-title":"Combining explainable machine learning, demographic and multi-omic data to inform precision medicine strategies for inflammatory bowel disease","volume":"17","author":"Gardiner","year":"2022","journal-title":"PLoS One."},{"key":"2026071707065383300_CIT0118","doi-asserted-by":"crossref","first-page":"107012","DOI":"10.1016\/j.cmpb.2022.107012","article-title":"Constrained multiple instance learning for ulcerative colitis prediction using histological images","volume":"224","author":"Del Amor","year":"2022","journal-title":"Comput Methods Programs Biomed."},{"issue":"5","key":"2026071707065383300_CIT0119","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/MEG.0000000000001952","article-title":"Deep learning enabled classification of Mayo endoscopic subscore in patients with ulcerative colitis","volume":"33","author":"Bhambhvani","year":"2021","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"2026071707065383300_CIT0120","doi-asserted-by":"crossref","first-page":"105996","DOI":"10.1016\/j.compbiomed.2022.105996","article-title":"Identification of potential crucial genes and key pathways shared in Inflammatory Bowel Disease and cervical cancer by machine learning and integrated bioinformatics","volume":"149","author":"Nguyen","year":"2022","journal-title":"Comput Biol Med."},{"issue":"9","key":"2026071707065383300_CIT0121","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.3390\/genes12091438","article-title":"Machine learning modeling from omics data as prospective tool for improvement of inflammatory bowel disease diagnosis and clinical classifications","volume":"12","author":"Stankovic","year":"2021","journal-title":"Genes"},{"issue":"2","key":"2026071707065383300_CIT0122","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.gie.2018.10.020","article-title":"Novel computer-assisted diagnosis system for endoscopic disease activity in patients with ulcerative colitis","volume":"89","author":"Ozawa","year":"2019","journal-title":"Gastrointest Endosc."},{"issue":"Supplement_1","key":"2026071707065383300_CIT0123","doi-asserted-by":"crossref","first-page":"i015","DOI":"10.1093\/ecco-jcc\/jjab232.014","article-title":"OP15 A new simplified histology artificial intelligence system for accurate assessment of remission in Ulcerative Colitis","volume":"16","author":"Villanacci","year":"2022","journal-title":"J Crohns Colitis."},{"issue":"1","key":"2026071707065383300_CIT0124","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.gie.2020.05.066","article-title":"Ulcer severity grading in video capsule images of patients with Crohn\u2019s disease: an ordinal neural network solution","volume":"93","author":"Barash","year":"2021","journal-title":"Gastrointest Endosc."},{"issue":"4","key":"2026071707065383300_CIT0125","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/ibd\/izab122","article-title":"Utilizing deep learning to analyze whole slide images of colonic biopsies for associations between eosinophil density and clinicopathologic features in active ulcerative colitis","volume":"28","author":"Vande Casteele","year":"2022","journal-title":"Inflamm Bowel Dis."},{"issue":"3","key":"2026071707065383300_CIT0126","doi-asserted-by":"crossref","first-page":"e694","DOI":"10.1002\/ctm2.694","article-title":"Single-cell RNA sequencing technologies and applications: a brief overview","volume":"12","author":"Jovic","year":"2022","journal-title":"Clin Transl Med"},{"issue":"5","key":"2026071707065383300_CIT0127","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1053\/j.gastro.2023.07.014","article-title":"Stricturing Crohn\u2019s disease single-cell RNA sequencing reveals fibroblast heterogeneity and intercellular interactions","volume":"165","author":"Mukherjee","year":"2023","journal-title":"Gastroenterology."},{"issue":"2","key":"2026071707065383300_CIT0128","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1053\/j.gastro.2020.04.074","article-title":"Single-cell analyses of colon and blood reveal distinct immune cell signatures of ulcerative colitis and Crohn\u2019s disease","volume":"159","author":"Mitsialis","year":"2020","journal-title":"Gastroenterology."},{"key":"2026071707065383300_CIT0129","doi-asserted-by":"crossref","first-page":"623691","DOI":"10.3389\/fimmu.2020.623691","article-title":"Intestinal stem cells and immune cell relationships: Potential therapeutic targets for inflammatory bowel diseases","volume":"11","author":"Hou","year":"2021","journal-title":"Front Immunol."},{"key":"2026071707065383300_CIT0130","doi-asserted-by":"crossref","first-page":"103912","DOI":"10.1016\/j.rinp.2021.103912","article-title":"Diagnosis and prognosis of epidemic inflammatory bowel disease under convolutional neural network algorithm and nonlinear equation model","volume":"22","author":"Lian","year":"2021","journal-title":"Results Phys."},{"issue":"5","key":"2026071707065383300_CIT0131","doi-asserted-by":"crossref","first-page":"e193963","DOI":"10.1001\/jamanetworkopen.2019.3963","article-title":"Performance of a deep learning model vs human reviewers in grading endoscopic disease severity of patients with ulcerative colitis","volume":"2","author":"Stidham","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"3","key":"2026071707065383300_CIT0132","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000507701","article-title":"Non-invasive colorectal cancer screening: an overview","volume":"7","author":"Tepus","year":"2020","journal-title":"Gastrointest Tumors"},{"issue":"5","key":"2026071707065383300_CIT0133","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/med.21893","article-title":"Inflammatory bowel disease biomarkers","volume":"42","author":"Liu","year":"2022","journal-title":"Med Res Rev."},{"key":"2026071707065383300_CIT0134","author":"U.S. Food and Drug Administration"},{"issue":"10080","key":"2026071707065383300_CIT0135","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(16)31711-1","article-title":"Crohn\u2019s disease","volume":"389","author":"Torres","year":"2017","journal-title":"Lancet"},{"issue":"5","key":"2026071707065383300_CIT0136","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1053\/j.gastro.2022.01.023","article-title":"What does disease progression look like in ulcerative colitis, and how might it be prevented","volume":"162","author":"Krugliak Cleveland","year":"2022","journal-title":"Gastroenterology."},{"issue":"4","key":"2026071707065383300_CIT0137","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/MOG.0000000000000849","article-title":"Management of refractory inflammatory bowel disease","volume":"38","author":"Gergely","year":"2022","journal-title":"Curr Opin Gastroenterol."},{"issue":"2","key":"2026071707065383300_CIT0138","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/ecco-jcc\/jjz131","article-title":"Outcomes and strategies to support a treat-to-target approach in inflammatory bowel disease: a systematic review","volume":"14","author":"Colombel","year":"2020","journal-title":"J Crohns Colitis."},{"issue":"3","key":"2026071707065383300_CIT0139","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1053\/j.gastro.2021.05.049","article-title":"Validation and update of the L\u00e9mann index to measure cumulative structural bowel damage in Crohn\u2019s disease","volume":"161","author":"Pariente","year":"2021","journal-title":"Gastroenterology."},{"issue":"9","key":"2026071707065383300_CIT0140","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S2468-1253(23)00154-1","article-title":"Difficult-to-treat inflammatory bowel disease: results from an international consensus meeting","volume":"8","author":"Parigi","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"2026071707065383300_CIT0141","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1053\/j.gastro.2021.07.042","article-title":"Extraintestinal manifestations of inflammatory bowel disease: current concepts, treatment, and implications for disease management","volume":"161","author":"Rogler","year":"2021","journal-title":"Gastroenterology."},{"issue":"6","key":"2026071707065383300_CIT0142","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1053\/j.gastro.2021.08.032","article-title":"Prevalence of primary sclerosing cholangitis in patients with inflammatory bowel disease: a systematic review and meta-analysis","volume":"161","author":"Barberio","year":"2021","journal-title":"Gastroenterology."},{"issue":"3","key":"2026071707065383300_CIT0143","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.gastro.2021.10.035","article-title":"Colorectal cancer in inflammatory bowel disease: mechanisms and management","volume":"162","author":"Shah","year":"2022","journal-title":"Gastroenterology."},{"issue":"1","key":"2026071707065383300_CIT0144","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1053\/j.gastro.2020.03.039","article-title":"Deep remission at 1 year prevents progression of early Crohn\u2019s disease","volume":"159","author":"Ungaro","year":"2020","journal-title":"Gastroenterology."},{"issue":"5","key":"2026071707065383300_CIT0145","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1053\/j.gastro.2020.10.065","article-title":"Selecting end points for disease-modification trials in inflammatory bowel disease: the SPIRIT Consensus From the IOIBD","volume":"160","author":"Berre","year":"2021","journal-title":"Gastroenterology."},{"issue":"2","key":"2026071707065383300_CIT0146","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41575-023-00854-4","article-title":"Deciphering the different phases of preclinical inflammatory bowel disease","volume":"21","author":"Rudbaek","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol."},{"issue":"6","key":"2026071707065383300_CIT0147","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1053\/j.gastro.2020.08.005","article-title":"Increased intestinal permeability is associated with later development of Crohn\u2019s disease","volume":"159","author":"Turpin","year":"2020","journal-title":"Gastroenterology."},{"issue":"11","key":"2026071707065383300_CIT0148","doi-asserted-by":"crossref","first-page":"101263","DOI":"10.1016\/j.xcrm.2023.101263","article-title":"Characterizing the pre-clinical phase of inflammatory bowel disease","volume":"4","author":"Vestergaard","year":"2023","journal-title":"Cell Rep Med"},{"issue":"12","key":"2026071707065383300_CIT0149","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/apt.13641","article-title":"Serologic microbial associated markers can predict Crohn\u2019s disease behaviour years before disease diagnosis","volume":"43","author":"Choung","year":"2016","journal-title":"Aliment Pharmacol Ther."},{"issue":"11","key":"2026071707065383300_CIT0150","first-page":"767","article-title":"Inflammatory bowel disease findings from the Nurses\u2019 Health study I and II","volume":"11","author":"Chan","year":"2015","journal-title":"Gastroenterol Hepatol"},{"issue":"1","key":"2026071707065383300_CIT0151","first-page":"14","article-title":"Familial and ethnic risk in inflammatory bowel disease","volume":"31","author":"Santos","year":"2018","journal-title":"Ann Gastroenterol"},{"issue":"2","key":"2026071707065383300_CIT0152","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41435-020-0092-x","article-title":"Genomic profiling of intestinal T-cell receptor repertoires in inflammatory bowel disease","volume":"21","author":"Saravanarajan","year":"2020","journal-title":"Genes Immun."},{"key":"2026071707065383300_CIT0153","doi-asserted-by":"crossref","first-page":"932373","DOI":"10.3389\/fcimb.2022.932373","article-title":"Reduced diversity of intestinal T-cell receptor repertoire in patients with Crohn\u2019s disease","volume":"12","author":"Hong","year":"2022","journal-title":"Front Cell Infect Microbiol."},{"issue":"5","key":"2026071707065383300_CIT0154","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/s41385-018-0046-z","article-title":"Expanded TCR\u03b2 CDR3 clonotypes distinguish Crohn\u2019s disease and ulcerative colitis patients","volume":"11","author":"Wu","year":"2018","journal-title":"Mucosal Immunol"},{"issue":"3","key":"2026071707065383300_CIT0155","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1053\/j.gastro.2022.12.007","article-title":"AGA clinical practice guideline on the role of biomarkers for the management of ulcerative colitis","volume":"164","author":"Singh","year":"2023","journal-title":"Gastroenterology."},{"issue":"12","key":"2026071707065383300_CIT0156","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S2468-1253(20)30300-9","article-title":"Prevalence of irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease in remission: a systematic review and meta-analysis","volume":"5","author":"Fairbrass","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"2026071707065383300_CIT0157","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1053\/j.gastro.2017.05.056","article-title":"Impaired intestinal permeability contributes to ongoing bowel symptoms in patients with inflammatory bowel disease and mucosal healing","volume":"153","author":"Chang","year":"2017","journal-title":"Gastroenterology."},{"issue":"7","key":"2026071707065383300_CIT0158","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.3390\/diagnostics13071230","article-title":"Impaired intestinal permeability assessed by confocal laser endomicroscopy\u2014a new potential therapeutic target in inflammatory bowel disease","volume":"13","author":"Chiriac","year":"2023","journal-title":"Diagnostics"},{"issue":"1","key":"2026071707065383300_CIT0159","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/ecco-jcc\/jjab178","article-title":"ECCO guidelines on therapeutics in ulcerative colitis: medical treatment","volume":"16","author":"Raine","year":"2022","journal-title":"J Crohns Colitis."},{"issue":"5","key":"2026071707065383300_CIT0160","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1053\/j.gastro.2020.01.006","article-title":"AGA clinical practice guidelines on the management of moderate to severe ulcerative colitis","volume":"158","author":"Feuerstein","year":"2020","journal-title":"Gastroenterology."},{"issue":"6","key":"2026071707065383300_CIT0161","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.cgh.2019.10.035","article-title":"Positioning therapies in the management of Crohn\u2019s disease","volume":"18","author":"Nguyen","year":"2020","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"1","key":"2026071707065383300_CIT0162","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/jama.2020.18936","article-title":"Management of Crohn disease: a review","volume":"325","author":"Cushing","year":"2021","journal-title":"JAMA."},{"issue":"5","key":"2026071707065383300_CIT0163","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1053\/j.gastro.2021.12.245","article-title":"How do we predict a patient\u2019s disease course and whether they will respond to specific treatments","volume":"162","author":"Verstockt","year":"2022","journal-title":"Gastroenterology."},{"issue":"10","key":"2026071707065383300_CIT0164","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1093\/ibd\/izaa210","article-title":"Defining the path forward for biomarkers to address unmet needs in inflammatory bowel diseases","volume":"26","author":"Honig","year":"2020","journal-title":"Inflamm Bowel Dis."},{"issue":"1","key":"2026071707065383300_CIT0165","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/apt.17248","article-title":"Effectiveness and safety of tofacitinib for ulcerative colitis: two-year results of the ICC Registry","volume":"57","author":"Straatmijer","year":"2023","journal-title":"Aliment Pharmacol Ther."},{"issue":"9","key":"2026071707065383300_CIT0166","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1365-2036.2011.04612.x","article-title":"Review article: loss of response to anti-TNF treatments in Crohn\u2019s disease","volume":"33","author":"Ben-Horin","year":"2011","journal-title":"Aliment Pharmacol Ther."},{"issue":"10","key":"2026071707065383300_CIT0167","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1093\/ibd\/izac259","article-title":"Influence of HLADQA1*05 genotype in adults with inflammatory bowel disease and anti-TNF treatment with proactive therapeutic drug monitoring: a retrospective cohort study","volume":"29","author":"Fuentes-Valenzuela","year":"2023","journal-title":"Inflamm Bowel Dis."},{"issue":"12","key":"2026071707065383300_CIT0168","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1111\/apt.17313","article-title":"Meta-analysis: the efficacy of therapeutic drug monitoring of anti-TNF-therapy in inflammatory bowel disease","volume":"57","author":"Sethi","year":"2023","journal-title":"Aliment Pharmacol Ther."},{"issue":"4","key":"2026071707065383300_CIT0169","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/ecco-jcc\/jjz162","article-title":"Therapeutic drug monitoring of biologics during induction to prevent primary non-response","volume":"14","author":"Sparrow","year":"2020","journal-title":"J Crohns Colitis."},{"key":"2026071707065383300_CIT0170","doi-asserted-by":"crossref","first-page":"646673","DOI":"10.3389\/fimmu.2021.646673","article-title":"A novel model based on serum biomarkers to predict primary non-response to infliximab in Crohn\u2019s disease","volume":"12","author":"Li","year":"2021","journal-title":"Front Immunol."},{"key":"2026071707065383300_CIT0171","article-title":"Development and validation of an interleukin-6 nomogram to predict primary non-response to infliximab in Crohn\u2019s disease patients","volume":"12:654985","author":"Chen","year":"2021","journal-title":"Front Pharmacol."},{"issue":"8","key":"2026071707065383300_CIT0172","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.cgh.2021.03.037","article-title":"Prediction of relapse after anti\u2013tumor necrosis factor cessation in Crohn\u2019s disease: individual participant data meta-analysis of 1317 patients from 14 studies","volume":"20","author":"Pauwels","year":"2022","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"5","key":"2026071707065383300_CIT0173","doi-asserted-by":"crossref","first-page":"752","DOI":"10.5009\/gnl20233","article-title":"Long-term outcomes after the discontinuation of anti-tumor necrosis factor-\u03b1 therapy in patients with inflammatory bowel disease under clinical remission: a Korean Association for the Study of Intestinal Disease Multicenter Study","volume":"15","author":"Song","year":"2021","journal-title":"Gut Liver"},{"issue":"1","key":"2026071707065383300_CIT0174","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1038\/s41467-021-22164-6","article-title":"Single-cell analyses of Crohn\u2019s disease tissues reveal intestinal intraepithelial T cells heterogeneity and altered subset distributions","volume":"12","author":"Jaeger","year":"2021","journal-title":"Nat Commun."},{"issue":"9","key":"2026071707065383300_CIT0175","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1177\/1357633X19849280","article-title":"Videoconference clinics improve efficiency of inflammatory bowel disease care in a remote and rural setting","volume":"26","author":"Ruf","year":"2020","journal-title":"J Telemed Telecare."},{"key":"2026071707065383300_CIT0176","doi-asserted-by":"crossref","first-page":"F1000 Faculty Rev-54","DOI":"10.12688\/f1000research.20928.1","article-title":"Precision medicine in inflammatory bowel disease: concept, progress and challenges","volume":"9","author":"Borg-Bartolo","year":"2020","journal-title":"F1000Research"},{"issue":"5","key":"2026071707065383300_CIT0177","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1053\/j.gastro.2021.09.077","article-title":"The future of precision medicine to predict outcomes and control tissue remodeling in inflammatory bowel disease","volume":"162","author":"Lamb","year":"2022","journal-title":"Gastroenterology."},{"issue":"9","key":"2026071707065383300_CIT0178","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1093\/ecco-jcc\/jjab051","article-title":"Results of the Seventh Scientific Workshop of ECCO: precision medicine in IBD\u2014what, why, and how","volume":"15","author":"Fiocchi","year":"2021","journal-title":"J Crohns Colitis."},{"issue":"6","key":"2026071707065383300_CIT0179","doi-asserted-by":"crossref","first-page":"1900131","DOI":"10.1002\/prca.201900131","article-title":"Classification of inflammatory bowel disease from formalin-fixed, paraffin-embedded tissue biopsies via imaging mass spectrometry","volume":"14","author":"Klein","year":"2020","journal-title":"Proteomics Clin Appl."},{"issue":"1","key":"2026071707065383300_CIT0180","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1038\/s41467-023-40156-6","article-title":"Macrophage and neutrophil heterogeneity at single-cell spatial resolution in human inflammatory bowel disease","volume":"14","author":"Garrido-Trigo","year":"2023","journal-title":"Nat Commun."},{"issue":"7","key":"2026071707065383300_CIT0181","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1053\/j.gastro.2023.02.031","article-title":"Artificial intelligence enabled histological prediction of remission or activity and clinical outcomes in ulcerative colitis","volume":"164","author":"Iacucci","year":"2023","journal-title":"Gastroenterology."},{"issue":"6","key":"2026071707065383300_CIT0182","doi-asserted-by":"crossref","first-page":"100124","DOI":"10.1016\/j.modpat.2023.100124","article-title":"Artificial intelligence enables quantitative assessment of ulcerative colitis histology","volume":"36","author":"Najdawi","year":"2023","journal-title":"Mod Pathol."},{"issue":"8","key":"2026071707065383300_CIT0183","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1080\/03007995.2021.1918072","article-title":"Adherence and persistence among patients with major depressive disorder enrolled in the vortioxetine tAccess Patient Support Program","volume":"37","author":"Lawrence","year":"2021","journal-title":"Curr Med Res Opin."},{"issue":"2","key":"2026071707065383300_CIT0184","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1172\/JCI129197","article-title":"Opportunities and challenges in using real-world data for health care","volume":"130","author":"Rudrapatna","year":"2020","journal-title":"J Clin Invest."},{"issue":"6","key":"2026071707065383300_CIT0185","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1177\/17407745211038524","article-title":"Characteristics of available studies and dissemination of research using major clinical data sharing platforms","volume":"18","author":"Vazquez","year":"2021","journal-title":"Clin Trials."},{"issue":"2","key":"2026071707065383300_CIT0186","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/ibd\/izab071","article-title":"The development and initial findings of a Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease (SPARC IBD)","volume":"28","author":"Raffals","year":"2022","journal-title":"Inflamm Bowel Dis."},{"issue":"3","key":"2026071707065383300_CIT0187","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/jgh.15764","article-title":"Hyperactive neutrophil chemotaxis contributes to anti-tumor necrosis factor-\u03b1 treatment resistance in inflammatory bowel disease","volume":"37","author":"Yau","year":"2022","journal-title":"J Gastroenterol Hepatol."},{"issue":"1","key":"2026071707065383300_CIT0188","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s13059-023-03016-6","article-title":"Effective methods for bulk RNA-seq deconvolution using scnRNA-seq transcriptomes","volume":"24","author":"Cobos","year":"2023","journal-title":"Genome Biol."},{"issue":"6663","key":"2026071707065383300_CIT0189","doi-asserted-by":"crossref","first-page":"eadh0301","DOI":"10.1126\/science.adh0301","article-title":"Conserved \u03b3\u03b4 T cell selection by BTNL proteins limits progression of human inflammatory bowel disease","volume":"381","author":"Dart","year":"2023","journal-title":"Science."},{"issue":"1","key":"2026071707065383300_CIT0190","doi-asserted-by":"crossref","first-page":"101300","DOI":"10.1016\/j.xcrm.2023.101300","article-title":"A personalized network framework reveals predictive axis of anti-TNF response across diseases","volume":"5","author":"Gerassy-Vainberg","year":"2023","journal-title":"Cell Rep Med"},{"issue":"1","key":"2026071707065383300_CIT0191","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.med.59.090506.155819","article-title":"The FDA critical path initiative and its influence on new drug development","volume":"59","author":"Woodcock","year":"2008","journal-title":"Annu Rev Med."},{"issue":"8","key":"2026071707065383300_CIT0192","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/d41573-019-00015-w","article-title":"The FNIH Biomarkers Consortium embraces the BEST","volume":"18","author":"Menetski","year":"2019","journal-title":"Nat Rev Drug Discov."},{"key":"2026071707065383300_CIT0193","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2147\/CEG.S343468","article-title":"Mucosal gene transcript signatures in treatment na\u00efve inflammatory bowel disease: a comparative analysis of disease to symptomatic and healthy controls in the European IBD-Character Cohort","volume":"15","author":"Vatn","year":"2022","journal-title":"Clin Exp Gastroenterol"},{"issue":"11","key":"2026071707065383300_CIT0194","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s11894-023-00895-4","article-title":"Precision dosing of anti-TNF therapy in pediatric inflammatory bowel disease","volume":"25","author":"Samuels","year":"2023","journal-title":"Curr Gastroenterol Rep."},{"key":"2026071707065383300_CIT0195","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3389\/fonc.2014.00141","article-title":"Co-development of diagnostic vectors to support targeted therapies and theranostics: essential tools in personalized cancer therapy","volume":"4","author":"Nicolaides","year":"2014","journal-title":"Front Oncol."},{"issue":"2","key":"2026071707065383300_CIT0196","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1208\/s12248-021-00574-0","article-title":"Cancer immunotherapy update: FDA-approved checkpoint inhibitors and companion diagnostics","volume":"23","author":"Twomey","year":"2021","journal-title":"AAPS J."},{"issue":"2","key":"2026071707065383300_CIT0197","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/ana.26860","article-title":"Biomarker qualification for neurofilament light chain in amyotrophic lateral sclerosis: theory and practice","volume":"95","author":"Benatar","year":"2024","journal-title":"Ann Neurol."},{"key":"2026071707065383300_CIT0198","doi-asserted-by":"crossref","first-page":"1177271920974652","DOI":"10.1177\/1177271920974652","article-title":"Opportunities and challenges for drug development in the current regulatory landscape","volume":"15","author":"Gromova","year":"2020","journal-title":"Biomark Insights"},{"key":"2026071707065383300_CIT0199","doi-asserted-by":"crossref","first-page":"1187095","DOI":"10.3389\/fneur.2023.1187095","article-title":"Data sharing in neurodegenerative disease research: challenges and learnings from the innovative medicines initiative public-private partnership model","volume":"14","author":"Bradshaw","year":"2023","journal-title":"Front Neurol."},{"issue":"1","key":"2026071707065383300_CIT0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jmoldx.2021.09.009","article-title":"Electronic health records and genomics: perspectives from the association for molecular pathology electronic health record (EHR) interoperability for Clinical Genomics Data Working Group","volume":"24","author":"Carter","year":"2022","journal-title":"J Mol Diagn."},{"issue":"1","key":"2026071707065383300_CIT0201","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1186\/s12864-023-09643-4","article-title":"The NIH Comparative Genomics Resource: addressing the promises and challenges of comparative genomics on human health","volume":"24","author":"Bornstein","year":"2023","journal-title":"BMC Genomics."},{"issue":"11","key":"2026071707065383300_CIT0202","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/d41573-022-00158-3","article-title":"Accelerating therapeutic discoveries for heart failure: a new public\u2013private partnership","volume":"21","author":"Shah","year":"2022","journal-title":"Nat Rev Drug Discov."}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/30\/Supplement_2\/S39\/57745731\/izae084.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/30\/Supplement_2\/S39\/57745731\/izae084.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T11:07:16Z","timestamp":1784286436000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/30\/Supplement_2\/S39\/7676454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":202,"journal-issue":{"issue":"Supplement_2","published-online":{"date-parts":[[2024,5,23]]},"published-print":{"date-parts":[[2024,5,23]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izae084","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,5]]},"published":{"date-parts":[[2024,5]]}}}